featured
2021 Top Story in Neurology: Neuroinfectious Diseases and Neuroimmunology
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Matos et al., Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series. Frontiers in Neurology, 2021 Aug 4;12:678924. doi: 10.3389
- Landi et al., Safety of Natalizumab reinfusion in Multiple Sclerosis patients during active Sars-Cov2 infection. Multiple Sclerosis and Related Disorders https://doi.org/10.1016/j.msard.2021.103345
- Sánchez van Kammen et al., Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia JAMA Neurology, 2021 Nov 1;78(11):1314-1323.
- Simpson-Yap et al., Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. Neurology, 2021 Nov 9;97(19):e1870-e1885.
- Patone et al., Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 2021 Oct 25;1-10. doi: 10.1038/s41591-021-01556-7.
- Novak et al., Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis. Multiple Sclerosis and Related Disorders. 2021 Sep 9;56:103251. doi: 10.1016/j.msard.2021.103251
Disclosure statements are available on the authors' profiles: